Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $369,791 | 258 | 63.0% |
| Food and Beverage | $75,086 | 3,092 | 12.8% |
| Consulting Fee | $73,643 | 33 | 12.5% |
| Travel and Lodging | $32,610 | 130 | 5.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $26,910 | 22 | 4.6% |
| Honoraria | $7,350 | 2 | 1.3% |
| Education | $1,334 | 30 | 0.2% |
| Grant | $87.90 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $80,366 | 285 | $0 (2024) |
| GENZYME CORPORATION | $68,648 | 175 | $0 (2023) |
| Acorda Therapeutics, Inc | $58,031 | 121 | $0 (2024) |
| ABBVIE INC. | $53,707 | 252 | $0 (2024) |
| Eisai Inc. | $47,058 | 126 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $43,868 | 63 | $0 (2024) |
| Biogen, Inc. | $37,585 | 221 | $0 (2024) |
| EMD Serono, Inc. | $34,698 | 277 | $0 (2024) |
| Lilly USA, LLC | $31,381 | 85 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $29,335 | 63 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79,452 | 507 | Eisai Inc. ($29,839) |
| 2023 | $80,800 | 500 | Otsuka America Pharmaceutical, Inc. ($27,581) |
| 2022 | $107,504 | 494 | Avanir Pharmaceuticals, Inc. ($29,050) |
| 2021 | $83,561 | 503 | Biogen, Inc. ($25,763) |
| 2020 | $49,268 | 387 | Allergan, Inc. ($16,768) |
| 2019 | $71,010 | 479 | Acorda Therapeutics, Inc ($34,790) |
| 2018 | $42,717 | 335 | GENZYME CORPORATION ($11,550) |
| 2017 | $72,500 | 364 | Teva Pharmaceuticals USA, Inc. ($21,754) |
All Payment Transactions
3,569 individual payment records from CMS Open Payments — Page 1 of 143
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/20/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $34.60 | General |
| Category: Immunology | ||||||
| 12/19/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Immunology and Neurology | ||||||
| 12/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.65 | General |
| Category: NEUROLOGY | ||||||
| 12/16/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 12/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/10/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $10.94 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $10.74 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $12.35 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $7.41 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $30.74 | General |
| 12/05/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.51 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: AMANTADINE | ||||||
| 12/03/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.64 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 950 | 1,359 | $347,990 | $119,426 |
| 2022 | 13 | 1,077 | 1,441 | $385,000 | $133,789 |
| 2021 | 11 | 1,163 | 1,543 | $453,140 | $158,048 |
| 2020 | 9 | 1,033 | 1,304 | $363,985 | $114,809 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 337 | 537 | $69,810 | $38,221 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 191 | $38,200 | $19,676 | 51.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 128 | 228 | $57,000 | $19,165 | 33.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 85 | 85 | $32,300 | $10,593 | 32.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 115 | 115 | $31,050 | $10,154 | 32.7% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 41 | 41 | $49,815 | $7,324 | 14.7% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 48 | 49 | $19,845 | $4,494 | 22.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 11 | 13 | $7,800 | $4,410 | 56.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 25 | 25 | $20,250 | $2,786 | 13.8% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $15,120 | $1,870 | 12.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 61 | $6,800 | $732.00 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 306 | 433 | $56,290 | $30,789 | 54.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 201 | 281 | $56,200 | $27,435 | 48.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 132 | 242 | $60,500 | $21,862 | 36.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 119 | 119 | $45,220 | $16,318 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 138 | 138 | $37,260 | $12,124 | 32.5% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 38 | 38 | $46,170 | $7,197 | 15.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 13 | 13 | $7,800 | $4,547 | 58.3% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2022 | 42 | 42 | $17,010 | $4,189 | 24.6% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 23 | 23 | $24,840 | $3,686 | 14.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 28 | 30 | $24,300 | $3,681 | 15.1% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 11 | 11 | $3,300 | $1,247 | 37.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 56 | $6,100 | $705.20 | 11.6% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 11 | 15 | $10.11 | $7.37 | 72.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 226 | 334 | $66,800 | $34,696 | 51.9% |
About Dr. Mayer Hasbani, MD
Dr. Mayer Hasbani, MD is a Clinical Neurophysiology healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780632968.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mayer Hasbani, MD has received a total of $586,812 in payments from pharmaceutical and medical device companies, with $79,452 received in 2024. These payments were reported across 3,569 transactions from 97 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($369,791).
As a Medicare-enrolled provider, Hasbani has provided services to 4,223 Medicare beneficiaries, totaling 5,647 services with total Medicare billing of $526,072. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Clinical Neurophysiology
- Location New Haven, CT
- Active Since 05/04/2006
- Last Updated 09/20/2013
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1780632968
Products in Payments
- UBRELVY (Drug) $60,734
- NUEDEXTA (Drug) $58,470
- AUBAGIO (Drug) $56,825
- Leqembi (Drug) $45,924
- INBRIJA (Drug) $44,154
- AUSTEDO (Drug) $42,734
- EMGALITY (Drug) $30,556
- Rebif (Biological) $29,116
- Austedo XR (Drug) $20,030
- Nuedexta (Drug) $14,436
- NOURIANZ (Drug) $13,413
- COPAXONE (Drug) $13,309
- AMPYRA (Drug) $12,933
- QULIPTA (Drug) $11,823
- Xadago (Drug) $10,959
- NUPLAZID (Drug) $5,318
- DISEASE STATE (Drug) $3,220
- ADUHELM (Biological) $2,774
- SD809-TD (Drug) $2,488
- TROKENDI XR (Drug) $2,242
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Clinical Neurophysiology Doctors in New Haven
Dr. Bogdan Patedakis Litvinov, Md, MD
Clinical Neurophysiology — Payments: $81,555
Dr. Moshe Hasbani, Md, MD
Clinical Neurophysiology — Payments: $12,531
Aline Herlopian
Clinical Neurophysiology — Payments: $11,058
Dr. Adithya Sivaraju, Md, MD
Clinical Neurophysiology — Payments: $176.28
Dr. Christopher Ransom, Md, Phd, MD, PHD
Clinical Neurophysiology — Payments: $59.25